Kidney damage in essential arterial hypertension: pathogenetic issues for early diagnostics
https://doi.org/10.18705/1607-419X-2019-25-1-6-13
Abstract
We review main issues of early diagnostics of kidney damage in patients with essential hypertension. The remodeling of renal vessels and the underlying mechanisms are discussed. The evidence-based data are reviewed to substantiate the use of laboratory methods for the kidney damage diagnostics (calculation of glomerular fltration rate and microalbuminuria). We discuss the role of Doppler methods in the assessment of intrarenal hemodynamics (the resistance index and blood flow acceleration time) for timely detection of changes in renal vessels and the choice of management strategy.
About the Authors
L. V. Melnikova
Academy of Advanced Medical Training of the Russian Federation
Russian Federation
Russian Federation
Lyudmila V. Melnikova, MD, PhD, DSc, Professor, Department of the General Medical Practice and Outpatient Therapy
2/1 Barrikadnaya street, Moscow, 125993
E. V. Osipova
Penza Institute of Advanced Medical Training, the Branch of the Academy of Advanced Medical Training of the Russian Federation
Russian Federation
Russian Federation
Elena V. Osipova, MD, Assistant, Department of Ultrasonic Diagnostics
Penza
References
1. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M et al. ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi:0.1093/eurheartj/ehy339
2. Grinshtejn YuN, Shabalin VV. Gipertenzivny nephropathy: occurrence and diagnostic markers. Rossijskie Meditsinskie Vesti = Russian Medical Messages. 2011;4:30–32. In Russian.
3. Kos T, Pacher R, Wimmer A, Bojic A, Hülsmann M, Frey B et al. Relationship between kidney function, hemodynamic variables and circulation big endothelin levels in patients with severe refractory heart failure. Wien Klin Wschr. 1998;110(3):89–95.
4. Levey AS, Greene T, Beck GJ, Caggiula AW, Kusek JW, Hunsicker LG et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD shown? Modifcation of Diet in Renal Disease Study group. J Am Soc Nephrol. 1999;10(11):2426–2439.
5. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, De Zeeuw D et al. Defnition and classifcation of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089–2100. doi:10.1111/j.1523-1755.2005.00365.x
6. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–1305. doi:10.1056/NEJMoa041031
7. Nanchikeeva ML, Kozlovskaya LV, Fomin VV, Rameev VV, Bulanov MN. Endotelialny dysfunction and remodeling of intra kidney vessels as basis of formation of a hypertensive nephropathy. Ul’trazvukovaya i Funkcional’naya Diagnostika = Ultrasonic and Functional Diagnostics. 2009;5:84– 94. In Russian.
8. Sever PS, Poulter NR. Blood pressure reduction is not the only determinant of outcome. Circulation. 2006;113(23):2754– 2774. doi:10.1161/CIRCULATIONHA.105.588020
9. Shulutko BI. Arterial Hypertension. SPb.: Renkor, 2000. 315 p. In Russian.
10. Florczak E, Januszewicz M, Januszewicz A, Prejbisz A, Kaczmarska M, Michałowska I et al. Relationship between renal resistive index and early target organ damage in patients with never treated essential hypertension. Blood Pressure. 2009;18(1–2):55–61. doi:10.1080/08037050902864078
11. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfeld MJ et al. Reappraisal of European guidelines on hypertension managements: a European Society of Hypertension Task Force document. Blood Press. 2009;18(6):308–347. doi:10.3109/08037050903450468
12. Nasrullaev MN, Vagapova GR, Bayazitova LI. Value of an ultrasonic method of a research in assessment of a kidney blood-groove at patients with arterial hypertension. Fundamental’nye Issledovaniya = Basic Research. 2011;9(1):104–106. In Russian.
13. Stokes J, Kannel WB, Wolf PA, D’Agostino RB, Cupples LA. Blood pressure as a risk factor of cardiovascular disease. The Framingham Study — 30 years of follow-up. Hypertension. 1989;12 (5):13–18.
14. Tylicki LI, Rutkowski B. Hypertensive nephropathy: pathogenesis, diagnosis and treatment. Pol Merkur Lekarski. 2003;14(80):168–173.
15. Ravera M, Noberasco G, Signori A, Re M, Filippi A, Cannavò R et al Left-ventricular hypertrophy and renal outcome in hypertensive patients in primary-care. Am J Hypertens. 2013;26 (5):700–707. doi:10.1093/ajh/hps100
16. Iskenderov BG. Cardiorenal syndrome in cardiological patients. Penza; 2014. 180 p. In Russian.
17. Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS et al Lower estimated glomerular fltration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int. 2011;79(12):1331–1340. doi:10.1038/ki.2010.550
18. Perera CA. Hypertennsive vascular disease: description and natural history. J Chron Dis. 1955:1(1):33–42.
19. Balanova YuA, Vilkov VG, Docenko AN, Deev AD, Ivanov VM, Kapustina AV. Results of the second stage of the monitoring of an epidemiological situation on an arterial hypertension in the Russian Federation (2005–2007) which is carried out within the federal target program “Prevention and Treatment of an Arterial Hypertension in the Russian Federation”. Information and Statistical Collection.M., 2008. 224 p. In Russian.
20. Shilov EM. Nephrology.M.: GEOTAR-Media, 2007. 688 p. In Russian.
21. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function: measured and estimated glomerular fltration rate. N Engl J Med. 2006;354(23):2473–2483. doi:10.1056/NEJMra054415
22. Ratner MYa, Serov VV, Tomilina NA. Renalny dysfunctions.M.: Medicina, 1977. 296 p. In Russian.
23. Tsioufs C, Dimitriadis K, Antoniadis D, Stefanadis C, Kallikazaros I. Inter-relationships of microalbuminuria with the other surrogates of the atherosclerotic cardiovascular disease in hypertensive subjects. Am J Hypertens. 2004;17(5):470–476. doi:10.1016/j.amjhyper.2004.02.008
24. Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE et al. Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study. Diabetes Care. 2006;29(3): 595–600.
25. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classifcation, and stratifcation. Am J Kidney Dis. 2002;39(2 Suppl 1):1–266.
26. Heine GH, Gerhart MK, Ulrich C, Köhler H, Girndt M. Renal Doppler resistance indices are associated with systemic atherosclerosis in kidney transplant recipients. Kidney Int. 2005; 68 (2):878–885. doi:10.1111/j.1523-1755.2005.00470.x
27. Pearce JD, Craven TE, Edwards MS, Corriere MA, Crutchley TA, Fleming SH et al. Associations between renal duplex parameters and adverse cardiovascular events in the elderly: a prospective cohort study. Am J Kidney Dis. 2010;55(2):281–290. doi:10.1053/j.ajkd.2009.10.044
28. Dzhanashiya PH, Nazarenko VA, Nikolaenko SA. Pharmacotherapy of cardiovascular diseases. Training course.M.: RGMU; 1998. P. 8–9. In Russian.
29. Viazzi F, Leoncini G, Derchi LE, Pontremoli R. Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient. J Hypertens. 2014;32(1):149–153. doi:10.1097/HJH.0b013e328365b29c
30. Sauvain J, Bourscheid D, Pierrat V. Duplex Doppler ultrasonography of intrarenal arteries. Normal and Pathological Aspects. Ann Radiol. 1991;34(4):237–247.
31. Galesić K, Brkljacić B, Sabljar-Matovinović M, Morović- Vergles J, Cvitković-Kuzmić A, Bozikov V. Renal vascular resistance in essential hypertension: duplex-Doppler ultrasonographic evaluation. Angiology. 2000;51(8):667–675.
32. Bauer JH, Reams GP, Wu Z. The aging hypetensive kidney: pathophysiology and therapeutic options. Am J Med. 1991;90 (4 В):21–27.
33. De Leeuw PW, Birkenhager WH. Renal involvement in essential hypertension and treatment effects. Neth J Med. 1995;47 (4):199–204.
34. Tublin ME, Bude RO, Platt JF. The resistive index in renal Doppler sonography: where do we stand? AJR Am J Roentgenol. 2003;180(4):885–892. doi:10.2214/ajr.180.4.1800885
35. Bude RO, DiPietro MA, Platt JF, Rubin JM, Miesowicz S, Lundquist C. Age dependency of the renal resistive index in healthy children. Radiology. 1992;184(2):469–473. doi:10.1148/radiology.184.2.1620850
36. Andriani G, Persico A, Tursini S, Ballone E, Cirotti D, Lelli Chiesa P. The renal-resistive index from the last 3 months of pregnancy to 6 months old. BJU Int. 2001;87(6):562–564.
37. Terry J, Rysavy J, Frick M. Intrarenal Doppler: characteristics of aging kidneys. J Ultrasound Med. 1992;11(12):647–651.
38. Hashimoto J, Ito S. Central pulse pressure and aortic stiffness determine renal hemodynamics: pathophysiological implication for microalbuminuria in hypertension. Hypertension. 2011;58(5):839– 846. doi:10.1161/HYPERTENSIONAHA.111.177469
39. Miyoshi K, Okura T, Tanino A, Kukida M, Nagao T, Higaki J. Usefulness of the renal resistive index to predict an increase in urinary albumin excretion in patients with essential hypertension. J Hum Hypertens. 2017;31(1):66–69. doi:10.1038/jhh.2016.38
40. Gazhonova VE, Zykova AS, CHistyakov AA, Roshchupkina SV, Romanova MD, Krasnova TN. Predictive value of the index of resistance of vessels of kidneys in assessment of progressing of a chronic disease of kidneys. Terapevticheskij Arhiv = Ter Arkh. 2015;87(6):29–33. In Russian
41. Doi Y, Iwashima Y, Yoshihara F, Kamide K, Takata H, Fujii T et al. Association of renal resistive index with target organ damage in essential hypertension. Am J Hypertens. 2012;25 (12):1292–1298. doi:10.1038/ajh.2012.113
42. Prejbisz A, Warchoł-Celińska E, Florczak E, Dobrowolski P, Klisiewicz A, Szwench-Pietrasz E et al. Renal resistive index in patients with true resistant hypertension: results from the RESIST-POL study. Kardiol Pol. 2016;74(2):142–150. doi:10.5603/KP.a2015.0114
43. Boddi M. Renal Ultrasound (and Doppler Sonography) in hypertension: an update. Adv Exp Med Biol. 2017;956:191–208. doi:10.1007/5584_2016_170
44. Doi Y, Iwashima Y, Yoshihara F, Kamide K, Hayashi S, Kubota Y et al. Renal resistive index and cardiovascular and renal outcomes in essential hypertension. Hypertension. 2012;60(3):770– 777. doi:10.1161/HYPERTENSIONAHA.112.196717
45. Lelyuk VG, Lelyuk SE. Physiology aspects and ultrasonic picture of kidney haemodynamics in normal conditions and in arterial hypertension: methodical recommendations. M., 2005. 40 p. In Russian.
46. Lopatkin NA, Morozov AV, Zhitnikova LN. Stenosis of a renal vein. M.: Meditsina, 1984. 144 p. In Russian.
47. Pykov MI, Korovina NA, Korosteleva EA, Tvorogova TM, Trufanova AV. Ultrasonic examination renal blood flow in children with autonomic dystonia. Ul’trazvukovaya Diagnostika = Ultrasonic Diagnostics. 2001;1:45– 48. In Russian.
48. Westheim A, Os I, Kjeldsen SE, Fonstelien E, Eide IK. Renal haemodynamic and sympathetic responses to head-up tilt in essential hypertension. Scand J Clin Lab Invest. 1990;50(8):815–822.
49. Mel’nikova LV, Bartosh LF. Changes of the intrarenal blood flow in orthostatic test in patients with arterial hypertension. Kazanskij Meditsinskij Zhurnal = Kazan Medical Magazine. 2014;20(6):553–558. In Russian
Review
For citations:
Melnikova L.V., Osipova E.V. Kidney damage in essential arterial hypertension: pathogenetic issues for early diagnostics. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2019;25(1):6-13. (In Russ.) https://doi.org/10.18705/1607-419X-2019-25-1-6-13
Views:
2187
Email this article 